quadrivalent recombinant norovirus vaccine / Chongqing Zhifei - LARVOL DELTA

Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (clinicaltrials.gov) - P3 | N=6600 | Active, not recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Recruiting ➔ Active, not recruiting

Enrollment closed • Gastrointestinal Disorder

Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Immunogenicity of Longkoma Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) Implanted in Populations of 6 Weeks and Older (ChiCTR) - P1/2 | N=580 | Completed | Sponsor: Guangxi Zhuang Autonomous Region Centre for Disease Control and Prevention; Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

New P1/2 trial • Gastroenterology • Gastrointestinal Disorder

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (clinicaltrials.gov) - P1/2 | N=580 | Completed | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Active, not recruiting ➔ Completed | Trial completion date: Dec 2024 ➔ Sep 2024

Trial completion • Trial completion date • Gastroenterology • Gastrointestinal Disorder

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (clinicaltrials.gov) - P1/2 | N=580 | Active, not recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Trial completion date: Jun 2024 ➔ Dec 2024 | Trial primary completion date: Feb 2024 ➔ Nov 2024

Trial completion date • Trial primary completion date • Gastroenterology • Gastrointestinal Disorder

Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (clinicaltrials.gov) - P3 | N=6600 | Recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Not yet recruiting ➔ Recruiting

Enrollment open • Gastrointestinal Disorder

Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (clinicaltrials.gov) - P3 | N=6600 | Not yet recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

New P3 trial • Gastrointestinal Disorder

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (clinicaltrials.gov) - P1/2 | N=580 | Active, not recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Recruiting ➔ Active, not recruiting | Trial completion date: Jun 2023 ➔ Jun 2024 | Trial primary completion date: Feb 2023 ➔ Feb 2024

Enrollment closed • Trial completion date • Trial primary completion date • Gastroenterology • Gastrointestinal Disorder

Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) (clinicaltrials.gov) - P1/2 | N=580 | Recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Trial completion date: Jul 2022 ➔ Jun 2023 | Trial primary completion date: Feb 2022 ➔ Feb 2023

Trial completion date • Trial primary completion date • Gastroenterology • Gastrointestinal Disorder